McMenamin ME, Nealon J, Lin Y, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis 2022; published online July 15. https://doi.org/10.1016/S1473-3099(22)00345-0—In this Article, the Summary has been corrected to say that between Dec 31, 2020, and March 16, 2022, 13·2 million vaccine doses were administered in Hong Kong's 7·4-million population. This correction has been made to the online version as of July 28, 2022, and will be made to the printed version.
. 2022 Jul 28;22(9):e239. doi: 10.1016/S1473-3099(22)00511-4
Correction to Lancet Infect Dis 2022; published online July 15. https://doi.org/10.1016/S1473-3099(22)00345-0
Issue date 2022 Sep.
© 2022 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9333949 PMID: 35908551
This corrects the article "Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study" on page 1435.